A5063761882- Glioma Diagnosis and Treatment
- Immune cells in cancer
- Synthesis and biological activity
- Acupuncture Treatment Research Studies
- Cancer Cells and Metastasis
- Protein Degradation and Inhibitors
- Peptidase Inhibition and Analysis
- Cancer therapeutics and mechanisms
- Bioactive Compounds and Antitumor Agents
- Ubiquitin and proteasome pathways
- Traditional Chinese Medicine Studies
- Immunotherapy and Immune Responses
- Pain Management and Placebo Effect
- Nanoplatforms for cancer theranostics
Nanjing University of Chinese Medicine
2024-2025
Guangzhou University of Chinese Medicine
2022
Glioma is a type of tumor occurring in the central nervous system. In recent decades, specific gene mutations and molecular aberrations have been used to conduct glioma classification clinical decisions. Siglec10 member sialic acid-binding immunoglobulin superfamily. this study, we investigated expression functions siglec10 gliomas. We analyzed patients with immunohistochemical (IHC) staining evaluated survival prognosis. The high had shorter prognosis than low patients, especially malignant...
Objective This study aimed to investigate the diagnostic value and underlying mechanisms of sialic acid-binding Ig-like lectin 9 (SIGLEC9) in gliomas. Patients Methods The Cancer Genome Atlas (TCGA) Chinese Glioma (CGGA) databases were used analyze association SIGLEC9 expression levels with tumor stages survival probability. Immunohistochemical staining analysis performed 177 glioma patients. Furthermore, related discovered about tumorigenesis, we reveal how functions macrophages through...